SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-49.67%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Cash on Hand
Cash on Hand as of September 2023 : $88.07 M
According to SCYNEXIS's latest financial reports the company has $88.07 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
SCYNEXIS - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $73.5 M | -29.65% |
| 2021-12-31 | $0.10 B | 12.3% |
| 2020-12-31 | $93.04 M | 92.18% |
| 2019-12-31 | $48.41 M | 9.64% |
| 2018-12-31 | $44.15 M | 0.6% |
| 2017-12-31 | $43.89 M | -25.08% |
| 2016-12-31 | $58.58 M | 24.69% |
| 2015-12-31 | $46.98 M | 45.72% |
| 2014-12-31 | $32.24 M | 2199.79% |
| 2013-12-31 | $1.4 M | -41.22% |
| 2012-12-31 | $2.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $13.31 M | -84.88% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.13 B | 56.28% | 🇺🇸 USA |
 Catalent CTLT | $0.22 B | 160.01% | 🇺🇸 USA |
 KemPharm KMPH | $82.84 M | -5.93% | 🇺🇸 USA |